Katie Martin
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 154 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 20.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,213 and has fallen 90.7% since, to $113 in 2025.
Across 154 payments — averaging $16.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$511
- AbbVie$426
- Corium, LLC$310
- Amarin Pharma, Inc.$153
- AstraZeneca$108
- Boehringer Ingelheim$102
- plus $951 from 19 others
What the payments were for
- Food & beverage$2,560100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 36 | $511 |
| AbbVie | 28 | $426 |
| Corium, LLC | 16 | $310 |
| Amarin Pharma, Inc. | 9 | $153 |
| AstraZeneca | 7 | $108 |
| Boehringer Ingelheim | 6 | $102 |
| Antares Pharma, Inc. | 6 | $101 |
| GSK | 6 | $96 |
| Supernus Pharmaceuticals, Inc. | 5 | $95 |
| Lilly USA, LLC | 5 | $89 |
| Amgen | 4 | $73 |
| Eisai Inc. | 4 | $70 |
| Neos Therapeutics, LP | 3 | $59 |
| Sumitomo Pharma America, Inc. | 2 | $55 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $55 |
| Upsher-smith Laboratories LLC | 2 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $36 |
| Biohaven Pharmaceuticals, Inc. | 2 | $34 |
| Acerus Pharmaceuticals Corporation | 2 | $29 |
| Merz North America, Inc. | 1 | $29 |
| Abbott | 1 | $21 |
| Pfizer | 1 | $21 |
| Mayne Pharma Commercial LLC | 1 | $16 |
| Johnson & Johnson | 1 | $16 |
| Ironshore Pharmaceuticals Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$120
How this compares
$2,560 in reported general payments places this provider in the 85th percentile of 15,456 family providers in Texas.
Other family in Katy
- David WeirDallas$959K
- Robin BeachHouston$428K
- April LopezMcAllen$417K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
- Angela AchaPflugerville$174K
- Susan BowlinIrving$164K
- Stephanie RodriguezCorpus Christi$159K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.